Literature DB >> 36136225

Stroke Prevention in Atrial Fibrillation.

Xu Gao1, Rod Passman2.   

Abstract

PURPOSE OF REVIEW: Atrial fibrillation is associated with a significant increase in stroke and systemic embolism. This review explores the areas of stroke prevention. RECENT
FINDINGS: In the last decade, NOAC has overtaken warfarin as the anticoagulant of choice for stroke prevention in AF. For patients unable to take anticoagulation, LAA closure has proven to be a valid option. The use of digital devices has led to widespread consumer-directed AF screening. It remains to be determined if all device detect AF pose the same amount of risk as recent studies have shown that short and infrequent episodes of AF may not benefit from anticoagulation. Stroke prevention is paramount in the management of AF. In this review we describe the risk factors contributing to stroke, recent advances in antithrombotic therapies, and the increasing role of digital health in guiding AF detection and stroke prevention.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Atrial fibrillation; Digital health; Left atrial appendage closure; Risk stratification; Stroke prevention; Wearable technology

Year:  2022        PMID: 36136225     DOI: 10.1007/s11886-022-01787-1

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   3.955


  57 in total

Review 1.  Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.

Authors:  Wen-Gen Zhu; Qin-Mei Xiong; Kui Hong
Journal:  Tex Heart Inst J       Date:  2015-02-01

Review 2.  Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis.

Authors:  A J Wagstaff; T F Overvad; G Y H Lip; D A Lane
Journal:  QJM       Date:  2014-03-14

3.  The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Christian Torp-Pedersen; Morten Lock Hansen; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2012-04-03       Impact factor: 5.249

4.  Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

Authors:  R G Hart; L A Pearce; R McBride; R M Rothbart; R W Asinger
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

5.  Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation.

Authors:  Yutao Guo; Stavros Apostolakis; Andrew D Blann; Haijun Wang; Xiaoning Zhao; Yu Zhang; Dexian Zhang; Jingling Ma; Yutang Wang; Gregory Y H Lip
Journal:  Int J Cardiol       Date:  2012-11-17       Impact factor: 4.164

6.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

7.  Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme.

Authors:  Stephan Rietbrock; Emma Heeley; Jonathan Plumb; Tjeerd van Staa
Journal:  Am Heart J       Date:  2008-07       Impact factor: 4.749

8.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

9.  Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.

Authors:  Chung-Wah Siu; Gregory Y H Lip; Kwok-Fai Lam; Hung-Fat Tse
Journal:  Heart Rhythm       Date:  2014-04-15       Impact factor: 6.343

10.  A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.

Authors:  Daniel E Singer; Yuchiao Chang; Leila H Borowsky; Margaret C Fang; Niela K Pomernacki; Natalia Udaltsova; Kristi Reynolds; Alan S Go
Journal:  J Am Heart Assoc       Date:  2013-06-21       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.